SLT therapy provides a safe treatment option for open-angle glaucoma patients who have had little success after taking conventional topical therapy for several years. With the added benefit of proven efficacy and safety as a first-line treatment in these patients, it seems the adoption of SLT in glaucoma treatment is likely to grow in coming years.
As a procedure that produces similar outcomes to those achieved with eyedrops, SLT offers the added advantage of eliminating the compliance problem that is often seen with patients on long-term eyedrop therapy (that is, with their eye drops and follow-up appointments).
Cost savings from a single laser treatment versus years of multiple eye drop regimes are also worth noting. This further adds to my confidence in the future of SLT in open-angle glaucoma treatment.
However, a key factor that is likely to make or break the uptake of this procedure by eye care practices worldwide is proper education of both patients and ophthalmologists. This will be vital in ensuring that only the most appropriate patients (early-stage glaucoma patients) are selected for treatment. By doing so, this promising technology can consistently be used to its full advantage and deliver the exemplary results for which it is capable.
Dr Andrij Savich
Dr Andrij Savich has no financial interest.
1. KF Damji, et al. Br J Ophthalmol. 1999;83:718–722.
2. AM Bovell, et al. Canadian Journal of Ophthalmology. 2011;doi:10.1016/j.jcjo.2011.07.016.
3. TR Kramer and RJ Noecker. Ophthalmol. 2001;108:773-79.
5. Y Barkana and M Belkin. Surv Ophthalmol. 2007;52:634-654.
6. JD Stein et al. Arch Ophthalmol. 2012;130:497-505.
7. Sihota R. Lasers in primary open angle glaucoma. Indian J Ophthalmol. 2011 Jan; 59(Suppl1):S114–S117.